Advair Diskus

A dry powdered inhaler formulation of fluticasone-salmeterol drug combination.
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fluticasone Propionate, Salmeterol Xinafoate Drug Combination

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial
We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food and Drug Administration (FDA… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2017
2017
Clinical Bioequivalence of OT329 SOLIS and ADVAIR DISKUS in Adults with Asthma.
RATIONALE OT329 SOLIS is a generic candidate for the branded asthma treatment, ADVAIR DISKUS (fluticasone propionate/salmeterol… (More)
Is this relevant?
2016
2016
Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial
Current pharmacokinetic (PK) bioequivalence guidelines do not account for batch-to-batch variability in study design or analysis… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.
n engl j med 364;26 nejm.org june 30, 2011 2473 comes such as asthma-related hospitalization, need for intubation, and even death… (More)
Is this relevant?
2011
2011
Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
BACKGROUND This report presents results of the first human study of a new dry powder inhaler (DPI-C). DPI-C uses reverse flow… (More)
Is this relevant?
2008
2008
NDA Number: 21-077, S-029 for Advair Diskus 250/50 Applicant Name: GlaxoSmithKline Date of Submission: October 30, 2007 PDUFA Goal Date: April 30, 2008 Proprietary Name: Advair Diskus Established…
2. Background There are several drug classes available for the relief of airflow obstruction in patients with COPD. These include… (More)
  • table 1
  • figure 1
  • table 1
  • figure 1
  • table 2
Is this relevant?
2005
2005
A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major U.S. drug chain pharmacies.
Context Although many Americans use the Internet to purchase drugs from Canadian pharmacies, no study has systematically… (More)
  • table 1
  • table 2
Is this relevant?
2004
2004
Adherence logger for a dry powder inhaler: a new device for medical adherence research.
BACKGROUND Adherence to inhaled steroid regimens is frequently poor. Finding ways to improve adherence depends on the ability to… (More)
Is this relevant?
2002
2002
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
BACKGROUND Options for step-down therapy include use of inhaled corticosteroids alone or in combination with a long-acting beta2… (More)
Is this relevant?
Review
2001
Review
2001
Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Several classes of medications are available for the treatment of asthma, and often they must be taken concurrently to achieve… (More)
Is this relevant?